Gene therapy on the RAC.
作者信息
Steele F R
机构信息
Molecular Therapy, Academic Press, San Diego, California 92037, USA.
出版信息
Mol Ther. 2000 Jan;1(1):1-2. doi: 10.1006/mthe.1999.0022.
PMID:10933902
Abstract
摘要
相似文献
1
Gene therapy on the RAC.
Mol Ther. 2000 Jan;1(1):1-2. doi: 10.1006/mthe.1999.0022.
2
Assessment of adenoviral vector safety and toxicity: report of the National Institutes of Health Recombinant DNA Advisory Committee.腺病毒载体安全性和毒性评估：美国国立卫生研究院重组DNA咨询委员会报告
Hum Gene Ther. 2002 Jan 1;13(1):3-13. doi: 10.1089/10430340152712629.
3
Gene therapy death prompts review of adenovirus vector.基因治疗死亡事件促使对腺病毒载体进行审查。
Science. 1999 Dec 17;286(5448):2244-5. doi: 10.1126/science.286.5448.2244.
4
Supervising gene therapy, openly.公开监督基因治疗。
Lancet. 1997 Jul 12;350(9071):79.
5
Potential risk of inadvertent germ-line gene transmission statement from the American Society of Gene Therapy to the NIH Recombinant DNA Advisory Committee, March 12, 1999.
Hum Gene Ther. 1999 Jun 10;10(9):1593-5. doi: 10.1089/10430349950017932.
6
Panel seeks better monitoring of experiments using people.小组寻求对人体实验进行更好的监测。
N Y Times Web. 2000 Mar 2:A20.
7
Who needs to know? Confusion reigns over the reporting of gene therapy deaths.
New Sci. 1999 Nov 13;164(2212):15.
8
Recombinant DNA Advisory Committee. U.S. Department of Health and Human Services, Public Health Service, National Institute of Health.重组DNA咨询委员会。美国卫生与公众服务部，公共卫生服务局，国立卫生研究院。
Hum Gene Ther. 2001 Nov 20;12(17):2129-51. doi: 10.1089/10430340152677467.
9
Human gene therapy: science under fire.人类基因疗法：受到抨击的科学。
Circulation. 2000 Mar 28;101(12):E9023-4. doi: 10.1161/01.cir.101.12.e9023.
10
NIH and FDA seek to increase oversight of gene therapy research.美国国立卫生研究院和美国食品药品监督管理局寻求加强对基因治疗研究的监管。
J Investig Med. 2000 May;48(3):169-71.
Zotero 插件